Invezz
21 Oct 2025, 15:00 UTC · 47w ago
Verdict
Headline leans bullish. We score WW +0.80.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
Which stocks this story touches
More positive than 88% of ticker scores this week
Shares rose 6% following a strategic partnership with Amazon Pharmacy to improve GLP-1 drug delivery.
More positive than 66% of ticker scores this week
Partnership with WeightWatchers and infrastructure investments underscore growing ambitions in healthcare and pharmacy.
Continue reading
5 related stories
More positive than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 53% of ticker scores this week
Its Zepbound medication is noted as a driver of the high-demand weight-loss drug market.
More positive than 53% of ticker scores this week
Mentioned as a partner of WeightWatchers with its Wegovy drug contributing to the revolutionized weight-loss industry.
More positive than 76% of relationship scores this week
[mutual] WW partners with Amazon Pharmacy to deliver GLP-1 weight-loss drugs and other prescriptions to its members.
More positive than 76% of relationship scores this week
[mutual] Novo Nordisk's Wegovy and Eli Lilly's Zepbound both compete in the GLP-1 weight-loss drug market.
More positive than 34% of relationship scores this week
[mutual] WW has a partnership with Novo Nordisk to distribute Wegovy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CNBC
2d ago
−48.5%
Price is moving against the score
$15.13 vs $29.40 close before publication (Oct 20) · not market-adjusted
WW chart →
